629 results match your criteria Wells Syndrome Eosinophilic Cellulitis

Wells Syndrome Presenting as Atypical Periorbital Cellulitis.

Ophthalmic Plast Reconstr Surg 2022 Jun 14. Epub 2022 Jun 14.

Department of Ophthalmology, Ophthalmic Plastic Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.

A 62-year-old man presented with diffuse, painless, left-sided preseptal edema, erythema, and woody induration extending to the left temple. The induration generated an orbital compartment syndrome with markedly elevated intraocular pressure necessitating lateral canthotomy and cantholysis. Although atypical for an infectious etiology, empiric broad-spectrum intravenous antibiotics were initiated with no improvement. Read More

View Article and Full-Text PDF

Unusual manifestations of adrenal insufficiency: A case report of hypopituitarism and Well's syndrome after apoplexy of a silent pituitary gonadotropic adenoma.

Medicine (Baltimore) 2022 Jun 3;101(22):e29274. Epub 2022 Jun 3.

Division of Endocrinology, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.

Rationale: Pituitary apoplexy occurs in about 8% of those with nonfunctioning pituitary adenoma. Subsequent hormone deficiency, especially corticotropic deficiency, is the most common finding. We describe the unusual manifestations of adrenal insufficiency that are usually overlooked in such cases, with the aim of raising awareness of this disease. Read More

View Article and Full-Text PDF

A Case of Well Leg Compartment Syndrome After Robot-assisted Laparoscopic Prostatectomy:With Review.

J Med Invest 2022 ;69(1.2):145-147

Department of Urology, Nippon Medical School, Tokyo, Japan.

Robot-assisted laparoscopic prostatectomy (RALP) for prostate cancer was introduced in 2000 and rapidly gained popularity. The Da Vinci Surgical System? can ensure improved local control of cancer and fewer perioperative complications. However, RALP is performed in the steep-Trendelenburg position (a combination of lithotomy and head-down tilt position/Lloyd-Davies position) to obtain a good surgical view, and as a result, well leg compartment syndrome (WLCS) can become a serious complication of RALP. Read More

View Article and Full-Text PDF

[Myocardial hypertrophy in a patient with eosinophilic dermatitis].

Zhonghua Xin Xue Guan Bing Za Zhi 2022 Apr;50(4):401-403

Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

View Article and Full-Text PDF

Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis.

J Allergy Clin Immunol 2022 Apr;149(4):1137-1149

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy; Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address:

Urticarial vasculitis (UV) is a rare cutaneous vasculitis of small vessels characterized by recurrent episodes of wheal-like lesions that tend to last more than 24 hours, healing with a residual ecchymotic postinflammatory hyperpigmentation. The histopathologic pattern of UV is that of leukocytoclastic vasculitis, consisting of fibrinoid necrosis of dermal vessels' walls and neutrophil-rich perivascular inflammatory infiltrates. Although its etiopahogenesis remains still undefined, UV is now regarded as an immune complex-driven disease with activation of the complement cascade, leading to exaggerated production of anaphylatoxins that are responsible for neutrophil recruitment and activation. Read More

View Article and Full-Text PDF

Eosinophilic Annular Erythema: A New Entity of Eosinophilic Dermatosis.

Cureus 2022 Feb 27;14(2):e22657. Epub 2022 Feb 27.

Dermatology Unit, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences, Casablanca, MAR.

Eosinophilic annular erythema (EAE) is a rare dermatosis. Its relationship with Wells syndrome (WS) is debated. We report a case treated with hydroxychloroquine. Read More

View Article and Full-Text PDF
February 2022

Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation.

Clin Rheumatol 2022 Jul 22;41(7):2233-2237. Epub 2022 Mar 22.

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

There have been hundreds of reports on mutations in the NLRP3 gene related to NLRP3-associated autoinflammatory disease, but few of these mutations have occurred as both germline and somatic mosaic mutations. In this case-based review, we report a 68-year-old man with an NLRP3-associated autoinflammatory disease. He developed secondary amyloidosis, including a renal and colorectal presentation in his 50 s. Read More

View Article and Full-Text PDF

Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone.

JAAD Case Rep 2022 Apr 9;22:11-13. Epub 2022 Feb 9.

Department of Dermatology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada.

View Article and Full-Text PDF

AA Amyloidosis complicating cryopyrin-associated periodic syndrome: a study on 86 cases including 23 French patients and systematic review.

Rheumatology (Oxford) 2022 Mar 9. Epub 2022 Mar 9.

Sorbonne Université, internal medicine department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, France.

Objective: Cryopyrin-associated periodic syndrome (CAPS) is a rare but treatable inherited autoinflammatory condition including familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) and chronic infantile neurologic cutaneous articular syndrome (CINCA). Our objective was to describe the main features of CAPS AA amyloidosis (AA-CAPS) associated and the efficacy of interleukin-1 inhibitors in this indication.

Methods: Retrospective study in France associated with a systematic literature review. Read More

View Article and Full-Text PDF

Wells syndrome as a presenting sign of COVID-19 in the setting of allergic rhinitis and iron deficiency anemia.

JAAD Case Rep 2022 May 3;23:27-30. Epub 2022 Mar 3.

Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.

View Article and Full-Text PDF

Wells Syndrome-Like Histologic Pattern Caused by a Permanent Tattoo.

Am J Dermatopathol 2022 Feb 2. Epub 2022 Feb 2.

University of California Davis School of Medicine, Sacramento, CA; Dermatology Department, Loma Linda University, Loma Linda, CA; and Dermatology Section, Geisinger Medical Center, Wilkes-Barre, PA.

Abstract: Tattoo reactions have become more common as tattoos gain visibility and popularity worldwide. A variety of inflammatory patterns have been described in association with tattoos- more commonly fibrosing, granulomatous, lichenoid, pseudolymphomatous, and spongiotic patterns. To date, there has been one case report of a Wells syndrome-like inflammatory pattern associated with a temporary Henna tattoo. Read More

View Article and Full-Text PDF
February 2022

Wells' syndrome following Oxford-AstraZeneca COVID-19 vaccination.

Y H Kim Y C Kim

J Eur Acad Dermatol Venereol 2022 05 31;36(5):e328-e330. Epub 2022 Jan 31.

Department of Dermatology, School of Medicine, Ajou University, Suwon, Korea.

View Article and Full-Text PDF

A three-generation Muckle-Wells syndrome family: Detailed family history, physical examination, and inter-departmental collaboration.

Mod Rheumatol Case Rep 2022 06;6(2):282-287

Center for Preventive Medical Sciences, Chiba University, Chiba, Japan.

Cryopyrin-associated periodic syndrome (CAPS) is a rare inherited autoinflammatory disease caused by gain-of-function mutations in the NLRP3 gene, with a genotype-phenotype correlation. The clinical presentation of each mutation has been previously studied. However, very few studies have reported on the clinical characteristics and treatment effectiveness across different generations within a family with the same mutation. Read More

View Article and Full-Text PDF

Bilateral Optic Disc Swelling as a Plausible Common Ocular Sign of Autoinflammatory Diseases: Report of Three Patients with Blau Syndrome or Cryopyrin-Associated Periodic Syndrome.

Life (Basel) 2021 Dec 19;11(12). Epub 2021 Dec 19.

Department of Pediatrics, Okayama City Hospital, Okayama City 700-8557, Japan.

The aim of this study is to describe bilateral optic disc swelling in three consecutive patients with Blau syndrome or cryopyrin-associated periodic syndrome at a single institution. Case 1 was a 30-year-old woman receiving 25 mg etanercept twice weekly who had been diagnosed as early-onset sarcoidosis by biopsy of skin rashes at 5 months old and genetically diagnosed with Blau syndrome with / mutation (N670K) at 13 years old. At 10 years old, she began to have uveitis with optic disc swelling in both eyes, resulting in macular degeneration and optic disc atrophy at 17 years old only when etanercept was introduced. Read More

View Article and Full-Text PDF
December 2021


Arerugi 2021 ;70(10):1391-1397

Department of Infectious Diseases and Respiratory Medicine, Fukushima Medical University Aizu Medical Center.

A-68-year-old man, who has allergic rhinitis with peripheral blood eosinophilia, hospitalized because of fever of unknown origin in May 2020. Five days after antibiotics were given, itchy exanthema occurred, followed by gland glass opacity on both lungs with bilateral pleural effusions. Since acute respiratory failure developed, bronchoscopy was hard to carry out. Read More

View Article and Full-Text PDF
December 2021

Rare Clinical Case of Cryopyrin-Associated Periodic Syndrome Presented with Ankylosing Spondylitis: A Case Report.

Curr Rheumatol Rev 2021 Nov 15. Epub 2021 Nov 15.

Onco-Hematologist, Department of Internal Medicine No.2, V.I. Vernadsky Crimean Federal University, Simferopol. Russian Federation.

Background: Cryopyrin-Associated Periodic Syndrome (CAPS) is a variety of clinical variants of autoinflammatory diseases. The pathology is based on a mutation in the NLRP3 gene encoding the cryopyrin protein, which leads to the uncontrolled production of interleukin-1β. Particular attention should be paid to the rarity of this disease and the lack of clinical knowledge about it in therapeutic and rheumatological practice, which leads to an erroneous diagnosis and the appointment of ineffective treatment for a long time, leading to the progression of the disease and disability of the patient. Read More

View Article and Full-Text PDF
November 2021

Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature review.

Ann Dermatol Venereol 2022 Jun 27;149(2):123-127. Epub 2021 Oct 27.

Department of Dermatology, CHU Lyon, Université Claude Bernard Lyon I, 69000 Lyon, France. Electronic address:

Background: Eosinophilic annular erythema (EAE) is a rare eosinophil-related skin disease which typically manifests with annular erythematous plaques and severe pruritus. Besides the diagnosis, the treatment of EAE is challenging since relevant published data are sparse.

Methods: The aim of this study was to assess the underlying diseases, treatments and outcomes of patients with EAE. Read More

View Article and Full-Text PDF

Novel missense mutation of the TP63 gene in a newborn with Hay-Wells/Ankyloblepharon-Ectodermal defects-Cleft lip/palate (AEC) syndrome: clinical report and follow-up.

Ital J Pediatr 2021 Sep 28;47(1):196. Epub 2021 Sep 28.

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Palermo, Italy.

Introduction: Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, also known as Hay-Wells syndrome, is a rare genetic syndrome with ectodermal dysplasia. About 100 patients have been reported to date. It is associated to a heterozygous mutation of the tumor protein p63 (TP63) gene, located on chromosome 3q28. Read More

View Article and Full-Text PDF
September 2021

Dupilumab in eosinophilic cellulitis (Wells' syndrome) - case report of a potential new treatment option.

J Dtsch Dermatol Ges 2021 11 22;19(11):1653-1655. Epub 2021 Sep 22.

Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article and Full-Text PDF
November 2021

Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.

J Eur Acad Dermatol Venereol 2022 Jan 5;36(1):e26-e28. Epub 2021 Oct 5.

Department of Dermatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

View Article and Full-Text PDF
January 2022

Eosinophilic annular erythema: A striking clinical presentation with potential systemic implications.

JAAD Case Rep 2021 Oct 18;16:33-36. Epub 2021 Aug 18.

Hospital Corporation of America Healthcare/University of South Florida Morsani College of Medicine Graduate Medical Education Programs, Department of Dermatology, Largo Medical Center, Largo, Florida.

View Article and Full-Text PDF
October 2021

Wells Syndrome Successfully Treated with Tripterygium Glycosides.

Clin Cosmet Investig Dermatol 2021 24;14:1029-1031. Epub 2021 Aug 24.

Department of Dermatology, The Fifth People's Hospital of Hainan Province, Branch of National Clinical Research Center for Skin and Immune Disease, Haikou, Hainan, People's Republic of China.

Wells syndrome (WS), also known as eosinophilic cellulitis, is a rare inflammatory dermatosis of unknown etiology that typically presents with pruritic cellulitis-like plaques. The first line treatment options for WS are topical or systemic corticosteroids, however, the development of side effects of systemic corticosteroids usually led to a switch to the second line therapy. Here, we reported a rare case of facial Wells syndrome misdiagnosed with bacterial cellulitis. Read More

View Article and Full-Text PDF

Recurrent Cellulitis-Like Episodes of the Lower Limbs and Acute Diarrhea in a 30-Year-Old Woman: A Case Report.

Am J Case Rep 2021 Aug 31;22:e932732. Epub 2021 Aug 31.

Department of Surgery, Evangelismos Hospital, Paphos, Cyprus.

BACKGROUND Wells syndrome is an uncommon inflammatory dermatosis that presents as tender or mildly pruritic cellulitis-like eruptions. The clinical presentation can include papular and nodular eruptions, annular plaques, vesicles, bullae, and urticaria. This syndrome can be promoted by inappropriate eosinophilic stimulation by factors that affect normal eosinophil cellular systems. Read More

View Article and Full-Text PDF

Wells Syndrome as a Rare Cause of Unilateral Ptosis.

Ocul Oncol Pathol 2021 Jun 28;7(3):190-193. Epub 2021 Jan 28.

Department of Ophthalmology, University Hospital of Antwerp, Edegem, Belgium.

We present a case of a woman with a swollen upper eyelid in ptosis, conjunctival nodules, and chemosis present for a couple of weeks. She did not respond to therapy for hordeolum or allergy. A biopsy followed by histopathological examination showed a large infiltration of eosinophilic granulocytes and flame figures, so the diagnosis of Wells syndrome was made. Read More

View Article and Full-Text PDF

Eosinophilic cellulitis with pustular lesions.

Int J Dermatol 2022 06 9;61(6):e227-e228. Epub 2021 Jul 9.

Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.

View Article and Full-Text PDF

Case of Muckle-Wells syndrome with obesity.

J Dermatol 2021 Sep 25;48(9):e438-e439. Epub 2021 May 25.

Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.

View Article and Full-Text PDF
September 2021

Cryopyrin-associated periodic syndrome with inflammatory bowel disease: A case study.

JGH Open 2021 May 9;5(5):629-631. Epub 2021 Mar 9.

Faculty of Health and Medical Sciences, The University of Adelaide Adelaide South Australia Australia.

Cryopyrin-associated Periodic Syndrome (CAPS) is a rare, genetic autoinflammatory condition associated with NLRP3 gene mutations, causing upregulated innate immunity. CAPS manifests as systemic inflammation, causing a constellation of symptoms on a clinical spectrum of phenotypical severity: Familial Cold Autoinflammatory Syndrome being the mildest, Muckle-Wells Syndrome moderate, and Neonatal Onset Multisystem Inflammatory Disease the most severe, with phenotype spectrum overlap. The treatment in Australia for CAPS is interleukin-1 blockade with receptor antagonist, anakinra. Read More

View Article and Full-Text PDF

Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry.

RMD Open 2021 05;7(2)

Division of Pediatric Rheumatology, Department of Paediatrics and Autoinflammation Reference Center Tuebingen, University Hospital Tuebingen, Tübingen, Germany.

Objective: To report the long-term safety and effectiveness of canakinumab, a fully human anti-interleukin 1β monoclonal antibody, in patients with cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) and neonatal-onset multisystem inflammatory disease (NOMID), in a real-world setting.

Methods: From December 2009 to December 2015, the β-Confident Registry prospectively enrolled patients with CAPS and non-CAPS conditions who received canakinumab per routine care and were prospectively followed for up to 6 years. The registry protocol did not mandate specific visits or procedures; however, all observed adverse events (AEs) and serious adverse events (SAEs) had to be recorded. Read More

View Article and Full-Text PDF

A Case of Hearing Impairment with Renal Dysfunction.

Indian J Nephrol 2021 Jan-Feb;31(1):64-66. Epub 2021 Jan 27.

Department of Nephrology, Manipal Hospitals, Bengaluru, Karnataka, India.

Hearing impairment in a patient with renal failure is an important clue towards etiologic diagnosis of kidney disease. Variety of hereditary diseases, developmental defects, and toxins involve these two organs. However, additional retinopathy is seen in quite a few diseases which include Alport's syndrome and Muckle-Wells syndrome (MWS). Read More

View Article and Full-Text PDF
January 2021